Cited by 44Hepatocellular Carcinoma Treatment and PrognosisHepatitis B Virus StudiesLiver Disease Diagnosis and Treatment

Opportunities to address gaps in early detection and improve outcomes of liver cancer

Open access
McMahon, Brian, Cohen, Chari, Brown Jr, Robert S, El-Serag, Hashem, Ioannou, George N, Lok, Anna S, Roberts, Lewis R, Singal, Amit G +1 more·2023·JNCI Cancer Spectrum

Abstract

Death rates from primary liver cancer (hepatocellular carcinoma [HCC]) have continued to rise in the United States over the recent decades despite the availability of an increasing range of treatment modalities, including new systemic therapies. Prognosis is strongly associated with tumor stage at diagnosis; however, most cases of HCC are diagnosed beyond an early stage. This lack of early detection has contributed to low survival rates. Professional society guidelines recommend semiannual ultrasound-based HCC screening for at-risk populations, yet HCC surveillance continues to be underused in clinical practice. On April 28, 2022, the Hepatitis B Foundation convened a workshop to discuss the most pressing challenges and barriers to early HCC detection and the need to better leverage existing and emerging tools and technologies that could improve HCC screening and early detection. In this commentary, we summarize technical, patient-level, provider-level, and system-level challenges and opportunities to improve processes and outcomes across the HCC screening continuum. We highlight promising approaches to HCC risk stratification and screening, including new biomarkers, advanced imaging incorporating artificial intelligence, and algorithms for risk stratification. Workshop participants emphasized that action to improve early detection and reduce HCC mortality is urgently needed, noting concern that many of the challenges we face today are the same or similar to those faced a decade ago and that HCC mortality rates have not meaningfully improved. Increasing the uptake of HCC screening was identified as a short-term priority while developing and validating better screening tests and risk-appropriate surveillance strategies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jncics/pkad034

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Improved screening and diagnostic techniques allow for earlier and more accurate detection, while changes in disease registry systems may enhance the ability to capture current epidemiological trends, potentially leading to higher reported prevalence rates.

    “Improved screening and diagnostic techniques allow for earlier and more accurate detection, while changes in disease registry systems may enhance the ability to capture current epidemiological trends, potentially leading to higher reported prevalence rates [27,28].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [32]Draft for Public Comment. CDC recommendations for hepatitis B screening and testing — United States, 2022. Centers for Disease Control and Prevention. Federal Register. 2022; 87(64): 19- 516. https://www.regulations.gov/document/CDC-2022-0044-0001. Accessed November 15, 2022.
  2. [33]National Institute on Alcohol Abuse and Alcoholism. Helping patients who drink too much: a clinician’s guide, 2005 edition. No. 07–3769. Bethesda, MD; 2007. https://www.issup.net/files/2017-07/Helping%20Patients%20Who%20Drink%20Too%20Much%20A%20Clinician%E2%80%99s%20Guide.pdf. Accessed December 17, 2022.

Cited by

Sorted by citations

Authors
McMahon, B., Cohen, C., Brown Jr, R. S., El-Serag, H., Ioannou, G. N., Lok, A. S., Roberts, L. R., Singal, A. G., & Block, T.
Affiliations
  • Alaska Native Tribal Health Consortium (US)
  • Hepatitis B Foundation (US)
  • Department of Medicine, Division of Gastroenterology and Hepatology, Weill Cornell Medicine , New York, NY, USA
  • Department of Medicine, Baylor College of Medicine , Houston, TX, USA
  • VA Puget Sound Health Care System (US)
  • University of Michigan (US)
  • Mayo Clinic (US)
  • The University of Texas Southwestern Medical Center (US)
Corresponding author
Cohen, Chari
Venue
JNCI Cancer Spectrum
Published
2023-05-02
Volume
7
Issue
3
ISSN
2515-5091 (ISSN-L)
OpenAlex
W4372330520
Cited by
44
References
102
Citations by year
2026: 8 · 2025: 18 · 2024: 18
FWCI
7.44
Type
journal article
Language
en
Open access
Locations
  • JNCI Cancer Spectrum (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Hepatitis B Foundation
Topics
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
  • Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
Keywords
hepatocellular carcinoma, liver cancer, early detection, cancer screening, HCC surveillance, screening uptake, risk stratification, biomarkers, artificial intelligence in imaging, risk prediction algorithm, HCC mortality, hepatitis B, barriers to screening
MeSH terms
Artificial Intelligence, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Prognosis, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review